Brief: Biosergen Q4 EBITDA Loss Widens To SEK 12.5 Mln

Biosergen AB

31/03/2023 10:45

March 31 (Reuters) - Biosergen AB  BIOSGN.ST :
    * Q4 EBITDA LOSS SEK 12.5 MILLION VERSUS LOSS SEK 9.9
MILLION YEAR
AGO 
    * Q4 OPERATING LOSS SEK 12.5 MILLION VERSUS LOSS SEK 9.9
MILLION
YEAR AGO 
    * Q4 NET LOSS SEK 12.4 MILLION VERSUS LOSS SEK 10 MILLION
YEAR AGO
    * BIOSERGEN PUBLISHES INTERIM REPORT FOR Q4 2022

Source text for Eikon:  ID:nWkr1DsJ7c 
Further company coverage:  BIOSGN.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))